You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-small cell lung carcinoma (NSCLC)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • +2 more
  • standard Radiotherapy
  • +3 more
  • (no location specified)
Oct 20, 2023

NSCLC Trial (Ivonescimab Injection, Pembrolizumab Injection)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Ivonescimab Injection
  • Pembrolizumab Injection
  • (no location specified)
Jun 9, 2023

Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

Not yet recruiting
  • Unresectable Lung Non-Small Cell Carcinoma
  • serplulimab plus chemotherapy as conversion treatment
  • (no location specified)
Apr 27, 2023

Circulating Tumor DNA and T Cell Repertoire Predict

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Brain Metastases
  • Whole-brain radiotherapy
  • Wuhan, Hubei, China
    Union hospital
Feb 12, 2023

NSCLC, Stage I Trial in Xi'an (Segmentectomy, Lobectomy)

Enrolling by invitation
  • NSCLC, Stage I
  • Segmentectomy
  • Lobectomy
  • Xi'an, Shannxi, China
    The Second Affiliated Hospital of Air Force Medical University U
Sep 7, 2023

Information Available in Chinese Non-Small-cell Lung Cancer

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Shanghai, Shanghai, China
    Department of Oncology, Shanghai pulmonary hospital
Feb 1, 2023

NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • (no location specified)
Mar 27, 2023

Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

Not yet recruiting
  • NSCLC
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Aug 6, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Non Small Cell Lung Cancer Trial in Montréal (increasing total fiber intake)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • increasing total fiber intake
    • Montréal, Quebec, Canada
      Centre hospitalier de l'Université de Montréal (CHUM)
    Apr 6, 2023

    Non-small Cell Lung Carcinoma Trial (BPI-361175)

    Not yet recruiting
    • Non-small Cell Lung Carcinoma
    • (no location specified)
    Oct 18, 2022

    Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

    Recruiting
    • Non-small Cell Lung Cancer
      • Guanzhou, China
        Sun Yat-sen University Cancer Center
      Aug 11, 2023

      Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • carboplatin chemotherapy
      • +2 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Nov 3, 2023

      NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

      Active, not recruiting
      Has Results
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 3, 2023

      Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

      Not yet recruiting
      • Local Advanced Non-small Cell Lung Cancer
      • (no location specified)
      Jun 2, 2023

      NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer Stage III
      • radiotherapy
      • +3 more
      • (no location specified)
      Sep 10, 2023

      NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)

      Recruiting
      • Non-small Cell Lung Cancer
      • Jette, Brussel, Belgium
        Universitair Ziekenhuis Brussel
      Jun 27, 2023

      NSCLC Trial in Guangzhou (BL-M07D1)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Nov 1, 2023

      Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

      Not yet recruiting
      • Lung Cancer, Nonsmall Cell
      • Lung Cancer Stage III
      • Nivolumab and Chemotherapy
      • +3 more
      • (no location specified)
      Aug 15, 2023

      NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

      Not yet recruiting
      • NSCLC
      • Non-small Cell Lung Cancer
      • Apatinib + Fluzoparib
      • Apatinib + Fluzoparib + Adebrelimab
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      Jun 27, 2023

      Efficacy and Safety of Anlotinib for Advanced Non-small Cell

      Completed
      • NSCLC
        • Wuhan, Hubei, China
          Hubei province
        Oct 19, 2022

        NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

        Recruiting
        • NSCLC
        • SBRT+LDRT
        • +2 more
        • Shanghai, Shanghai, China
          Shanghai Chest Hospital
        Apr 2, 2023

        Advanced NSCLC Trial (Trilaciclib+Envafolimab+Docetaxel, Envafolimab+Docetaxel, Docetaxel)

        Not yet recruiting
        • Advanced Non-Small Cell Lung Cancer
        • (no location specified)
        Jun 16, 2023

        NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Feb 16, 2023

        NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • +5 more
        • Duarte, California
        • +1 more
        Dec 7, 2022